Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kazia Therapeutics Limited - American Depositary Shares (NQ:KZIA)

6.160 -0.100 (-1.60%)
Streaming Delayed Price Updated: 3:16 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kazia Therapeutics Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Friday? ↗
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday? ↗
Kazia Therapeutics updates paxalisib's regulatory progress after FDA discussions on glioblastoma data, highlighting plans for a pivotal Phase 3 trial. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
7 Top Stocks Under $10: July 2024 Edition ↗
There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader. 
Via InvestorPlace
News headline image
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making? ↗
Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates. 
Via InvestorPlace
News headline image
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics ↗
Kazia Therapeutics stock is a fast mover in both directions and has long-term rally potential after Kazia Therapeutics' clinical victory. 
Via InvestorPlace
News headline image
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
S&P 500 Rises Over 1%; Citigroup Reports Upbeat Q2 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
The Benzinga Stock Whisper highlights five stocks weekly that saw increased interest from readers and could have upcoming catalysts and items investors should be watching. 
Via Benzinga
News headline image
From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher ↗
If you’ve read all the warnings and still want to jump into some of the top penny stocks to buy, focus on the key fundamentals. 
Via InvestorPlace
News headline image
Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June ↗
 
Via Benzinga
Topics Economy Stocks
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday 
Via InvestorPlace
News headline image
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns ↗
Silk recalls are a hot topic on Thursday as the plant-based milk alternative is being pulled from shelves due to listeria concerns. 
Via InvestorPlace
Topics Product Recall
News headline image
FCEL Stock Alert: FuelCell Energy Pops on Korean Market Update ↗
FuelCell Energy stock is up on Thursday as FCEL investors are excited about the company's Korean presentation and expansion news. 
Via InvestorPlace
News headline image
JOBY Stock Pops After Completing 523-Mile eVTOL Flight ↗
Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft. 
Via InvestorPlace
News headline image
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains ↗
Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.